Patent · US Active

Methods of treating cancer, infectious disease, and autoimmune disease using chemokines

US12427183B2 · kind B2 · utility

0Cited by
1References
14Claims
0Family size

Assignee

Inventor

Key dates

Filing dateNov 10, 2021
Grant dateSep 30, 2025
Priority date
Expiry dateAug 1, 2044

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The current invention is related to the prevention and treatment of diseases including cancer, autoimmune disease, and infectious disease using chemokines and the receptors to which they agonize. It has been found that certain chemokines, including CXCL4, CXCL9, CXCL10, and CXCL12 as well as CCL5 have various effects on toll-like receptors in various cell types and these can be utilized for disease treatment and prevention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.